Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Mouse models in the study of the Ets family of transcription factors

Abstract

The Ets family of transcription factors is one of a growing number of master regulators of development. This family was originally defined by the presence of a conserved DNA binding domain, the Ets domain. To date, nearly 30 members of this family have been identified and implicated in a wide range of physiological and pathological processes. Despite the likely importance of Ets-family members, each of their precise roles has not been delineated. Herein, we describe the elucidation of essential functions of a few of these family members in vivo using knockout mouse models. Of the knockouts generated to date, the majority shows important functions in hematopoiesis, ranging from PU.1, a principle regulator of myelo-lymphopoiesis, to Spi-B which regulates the proper function of terminally differentiated cells. Ets1 was shown to be of intermediate importance as a regulator of pan-lymphoid development. Other Ets family members such as Fli1 and TEL1 display distinct and/or overlapping functions in vasculo/angiogenesis, hemostasis and hematopoiesis. The remaining knockouts generated, Ets2 and Er81, show non-hematopoietic defects related to extraembryonic development and neurogenesis, respectively. The pioneering group of knockout models described reveals only the most distinct functions of each of these Ets family members. A better understanding of the roles and hierarchies of Ets family members in cellular differentiation will come with the generation of new null alleles in previously untargeted family members, more mutant alleles in members already disrupted, double knockouts, ES cell differentiation and chimera rescue experiments, and tissue-specific inducible knockouts.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Anderson KL, Perkin H, Surh CD, Venturini S, Maki RA and Torbett BE. . 2000 J. Immunol. 164: 1855–1861.

  • Anderson KL, Smith KA, Conners K, McKercher SR, Maki RA and Torbett BE. . 1998a Blood 91: 3702–3710.

  • Anderson KL, Smith KA, Pio F, Torbett BE and Maki RA. . 1998b Blood 92: 1576–1585.

  • Arber S, Ladle DR, Lin JH, Frank E and Jessell TM. . 2000 Cell 101: 485–498.

  • Barton K, Muthusamy N, Fischer C, Ting CN, Walunas TL, Lanier LL and Leiden JM. . 1998 Immunity 9: 555–563.

  • Bassuk AG and Leiden JM. . 1997 Adv. Immunol. 64: 65–104.

  • Bhat NK, Thompson CB, Lindsten T, June CH, Fujiwara S, Koizumi S, Fisher RJ and Papas TS. . 1990 Proc. Natl. Acad. Sci. USA 87: 3723–3727.

  • Bories J-C, Willerford DM, Grevin D, Davidson L, Camus A, Martin P, Stehelin D and Alt FW. . 1995 Nature 377: 635–638.

  • Chen J, Lansford R, Stewart V, Young F and Alt FW. . 1993 Proc. Natl. Acad. Sci. USA 90: 4528–4532.

  • DeKoter RP, Walsh JC and Singh H. . 1998 EMBO J. 17: 4456–4468.

  • Fisher RC, Lovelock JD and Scott EW. . 1999 Blood 94: 1283–1290.

  • Fisher RC and Scott EW. . 1998 Stem Cells 16: 25–37.

  • Garrett-Sinha LA, Su GH, Rao S, Kabak S, Hao Z, Clark MR and Simon MC. . 1999 Immunity 10: 399–408.

  • Ghysdael J and Boureux A. . 1997 Oncogenes as Transcriptional Regulators, Vol. 1: Progress in Gene Expression. Yaniv M and Ghysdael J. (eds). Birkhauser Verlag: Basel pp. 29–88.

  • Graves BJ and Petersen JM. . 1998 Adv. Cancer Res. 75: 1–55.

  • Guerriero A, Langmuir PB, Spain LM and Scott EW. . 2000 Blood 95: 879–885.

  • Hart A, Melet F, Grossfeld P, Chien K, Jones C, Tunnacliffe A, Favier R and Bernstein A. . 2000 Immunity 13: 167–177.

  • Henkel GW, McKercher SR, Leenen PJ and Maki RA. . 1999 Blood 93: 2849–2858.

  • Henkel GW, McKercher SR, Yamamoto H, Anderson KL, Oshima RG and Maki RA. . 1996 Blood 88: 2917–2926.

  • Iwama A, Zhang P, Darlington GJ, McKercher SR, Maki R and Tenen DG. . 1998 Nucl. Acids Res. 26: 3034–3043.

  • Lichanska AM, Browne CM, Henkel GW, Murphy KM, Ostrowski MC, McKercher SR, Maki RA and Hume DA. . 1999 Blood 94: 127–138.

  • McKercher SR, Torbett BE, Anderson KL, Henkel GW, Vestal DJ, Baribault H, Klemsz M, Feeney AJ, Wu GE, Paige CJ and Maki RA. . 1996 EMBO J. 15: 5647–5658.

  • Melet F, Motro B, Rossi DJ, Zhang L and Bernstein A. . 1996 Molec. Cell. Biol. 16: 2708–2718.

  • Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y and Honjo T. . 2000 Cell 102: 553–563.

  • Muthusamy N, Barton K and Leiden JM. . 1995 Nature 377: 639–642.

  • Orkin SH. . 1998 Int. J. Dev. Biol. 42: 927–934.

  • Orkin SH, Porcher C, Fujiwara Y, Visvader J and Wang LC. . 1999 Cancer Res. 59: 1784s–1787s; discussion 1788s.

  • Papas TS, Bhat NK, Spyropoulos DD, Mjaatvedt AE, Vournakis J, Seth A and Watson DK. . 1997 Leukemia 11: 557–566.

  • Pio F, Kodandapani R, Ni CZ, Shepard W, Klemsz M, McKercher SR, Maki RA and Ely KR. . 1996 J. Biol. Chem. 271: 23329–23337.

  • Ray D, Bosselut R, Ghysdael J, Mattei MG, Tavitian A and Moreau-Gachelin F. . 1992 Mol. Cell. Biol. 12: 4297–4304.

  • Ray-Gallet D, Mao C, Tavitian A and Moreau-Gachelin F. . 1995 Oncogene 11: 303–313.

  • Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, Catalan N, Forveille M, Dufourcq-Labelouse R, Gennery A, Tezcan I, Ersoy F, Kayserili H, Ugazio AG, Brousse N, Muramatsu M, Notarangelo LD, Kinoshita K, Honjo T, Fischer A and Durandy A. . 2000 Cell 102: 565–575.

  • Scott EW, Fisher RC, Olson MC, Kehrli EW, Simon MC and Singh H. . 1997 Immunity 6: 437–447.

  • Scott EW, Simon MC, Anastasi J and Singh H. . 1994 Science 265: 1573–1577.

  • Simon MC. . 1998 Semin Immunol 10: 111–118.

  • Spain LM, Guerriero A, Kunjibettu S and Scott EW. . 1999 J. Immunol. 163: 2681–2687.

  • Spyropoulos DD, Pharr PN, Lavenburg KR, Jackers P, Papas TS, Ogawa M and Watson DK. . 2000 Mol. Cell. Biol. 20: 5643–5652.

  • Su GH, Chen HM, Muthusamy N, Garrett-Sinha LA, Baunoch D, Tenen DG and Simon MC. . 1997 EMBO J. 16: 7118–7129.

  • Tondravi MM, McKercher SR, Anderson K, Erdmann JM, Quiroz M, Maki R and Teitelbaum SL. . 1997 Nature 386: 81–84.

  • Walunas TL, Wang B, Wang CR and Leiden JM. . 2000 J. Immunol. 164: 2857–2860.

  • Wang LC, Kuo F, Fujiwara Y, Gilliland DG, Golub TR and Orkin SH. . 1997 EMBO J. 16: 4374–4383.

  • Wang LC, Swat W, Fujiwara Y, Davidson L, Visvader J, Kuo F, Alt FW, Gilliland DG, Golub TR and Orkin SH. . 1998 Genes Dev. 12: 2392–2402.

  • Watson DK, Li R, Sementchenko VI, Mavrothalassitis G and Seth A. . 2001 Encyclopedia of Cancer. Bertino JR. (ed.). Academic Press: San Diego.

  • Yamamoto H, Flannery ML, Kupriyanov S, Pearce J, McKercher SR, Henkel GW, Maki RA, Werb Z and Oshima RG. . 1998 Genes Dev. 12: 1315–1326.

Download references

Acknowledgements

This article is dedicated to the memory of Dr Takis S Papas, a mentor, scientific colleague and friend from the beginning. We thank Dennis K Watson and Mark P Rubinstein for helpful suggestions. This work was supported in part by National Institutes of Health Grant P01CA78582.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bartel, F., Higuchi, T. & Spyropoulos, D. Mouse models in the study of the Ets family of transcription factors. Oncogene 19, 6443–6454 (2000). https://doi.org/10.1038/sj.onc.1204038

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204038

Keywords

This article is cited by

Search

Quick links